| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:Deox B 7,4
CAS:674786-37-9
Package:1removed
|
4H-1-Benzopyran-4-one, 2,3-dihydro-3-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy- manufacturers
- Deox B 7,4
-
- $1520.00
-
2026-05-11
- CAS:674786-37-9
- Purity:
- Supply Ability: 10g
|
| | 4H-1-Benzopyran-4-one, 2,3-dihydro-3-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy- Basic information |
| | 4H-1-Benzopyran-4-one, 2,3-dihydro-3-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy- Chemical Properties |
| Boiling point | 520.9±50.0 °C(Predicted) | | density | 1.264±0.06 g/cm3(Predicted) | | pka | 9.90±0.10(Predicted) |
| | 4H-1-Benzopyran-4-one, 2,3-dihydro-3-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy- Usage And Synthesis |
| Description | Deox B 7,4 is a reversible microtubule inhibitor. It acts by increasing lysosomal V-ATPase activity and lysosome acidity. | | Uses | (Rac)-Deox B 7,4, a homoisoflavanoid compound, inhibits microtubule polymerization via binding near the colchicine site and promote reversible G2 arrest. (Rac)-Deox B 7,4 possesses nanomolar anti-leukemic activity[1]. | | References | [1] Dannie Bernard, et al. Select microtubule inhibitors increase lysosome acidity and promote lysosomal disruption in acute myeloid leukemia (AML) cells. Apoptosis. 2015 Jul;20(7):948-59. DOI:10.1007/s10495-015-1123-3 |
| | 4H-1-Benzopyran-4-one, 2,3-dihydro-3-[(3-hydroxy-4-methoxyphenyl)methyl]-7-methoxy- Preparation Products And Raw materials |
|